ZLD 0.63% 80.0¢ zelira therapeutics limited

Ann: Zelda to merge with US-based Ilera Therapeutics, page-179

  1. 1,036 Posts.
    lightbulb Created with Sketch. 239
    NEW WORLD ORDER
    https://www.europeancannabiscorp.com/about/company-overview

    EuroCann to be listed on the London Stock Exchange by November 2019
    Owned by Merchant Group
    CEO Harry Karalis - Aims to have a market cap 1.5 billion
    Owns Hapa Pharmaceuticals Germany
    Merchant Group Owns 4% Zelda
    Merchant Group Just purchased 11.5% of Auscan

    Something is happening on a world wide scale in the Medical Cannabis Industry.....are the ducks are being put in a row?

    A number of Zelda trail results will be outs soon, looks like companies and Australian founders are coming together to maximise the potential in US and European Markets and leverage off Zelda trials.

    Potentially Auscann's Hard Shell Capsules used as a delivery method world wide for Zelda Formulations.... Just a thought and something Ido Kanyon alluded to in the Auscann Webinar.

    CANOPY OUT OF AUSCANN
    Canopy are out of Auscann which I dont know what to make of this yet... are they shifting away from Medical Cannabis?

    Was Bruce Linton the driving force of Medical Cannabis @ Canopy

    Is Canopy/Constellation Brands focusing more on the Food & Beverage Sector?

    Is there a conflict between Spectrum and Auscann and maybe Zelda?

    Is Spectrum performing and gaining access to US/European Markets?

    Have Spectrum fallen behind do they have any completed clinical trials or trials in progress?

    DYOR - Any thoughts welcome

 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
(20min delay)
Last
80.0¢
Change
0.005(0.63%)
Mkt cap ! $9.077M
Open High Low Value Volume
80.0¢ 80.0¢ 80.0¢ $2.442K 3.052K

Buyers (Bids)

No. Vol. Price($)
1 7894 76.0¢
 

Sellers (Offers)

Price($) Vol. No.
80.0¢ 7243 1
View Market Depth
Last trade - 13.20pm 09/08/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.